Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Open Label, Parallel-group, Multi-centre Trial to Compare the Efficacy and Safety of TachoSil® Versus Standard Haemostatic Treatment in Cardiovascular Surgery

NCT00440401 is registered in ClinicalTrials.gov with Nycomed as lead sponsor.

NCT NCT00440401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Open Label, Parallel-group, Multi-centre Trial to Compare the Efficacy and Safety of TachoSil® Versus Standard Haemostatic Treatment in Cardiovascular Surgery
Lead sponsor
Nycomed
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2007
Completion date
November 30, 2007
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular surgery, haemorrhage, haemostasis